Greater Cannabis Company (GCAN) Interest Expenses (2016 - 2021)
Greater Cannabis Company's (GCAN) quarterly Interest Expenses came in at $44318.0 in Q4 2021, up 13.54% year-on-year from $39034.0 in Q4 2020, and up 13.54% quarter-over-quarter from $39034.0 in Q4 2020.
Greater Cannabis Company (GCAN) Interest Expenses (2016 - 2021) Analysis & Trends
Greater Cannabis Company's Interest Expenses history runs 5 years deep, the most recent figure standing at $44318.0 for Q4 2021.
- On a quarterly basis, Interest Expenses rose 13.54% year-over-year to $44318.0 in Q4 2021; TTM through Dec 2021 was $44318.0, a 13.54% increase from a year earlier, with the FY2021 full-year figure at $44318.0, up 13.54% from the prior year.
- Interest Expenses improved to $44318.0 in Q4 2021 per GCAN's latest filing, from $39034.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $44318.0 in Q4 2021 and bottomed at -$2022.0 in Q4 2017.
- The 4-year median for Interest Expenses is $1565.0 (2018), against an average of $11184.1.
- Across the five-year window, Interest Expenses slumped 169.6% in 2017 and jumped 2035.33% in 2018, its largest moves.
- Year by year, Interest Expenses stood at -$2022.0 in 2017, then jumped by 817.85% to $14515.0 in 2018, then surged by 168.92% to $39034.0 in 2020, then increased by 13.54% to $44318.0 in 2021.
- Per Business Quant, the three latest GCAN Interest Expenses figures stand at $44318.0 (Q4 2021), $39034.0 (Q4 2020), and $14515.0 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Greater Cannabis Company | 255,226.94 | 255,226.94 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 44,318.00 |
| Dec 31, 2021 | 44,318.00 |
| Dec 31, 2020 | 39,034.00 |
| Dec 31, 2020 | 39,034.00 |
| Sep 30, 2018 | 14,515.00 |
| Sep 30, 2018 | 14,515.00 |
| Jun 30, 2018 | 2,218.00 |
| Jun 30, 2018 | 2,218.00 |
| Mar 31, 2018 | 1,565.00 |
| Mar 31, 2018 | 1,565.00 |
| Dec 31, 2017 | -2,022.00 |
| Dec 31, 2017 | -2,022.00 |
| Sep 30, 2017 | -750.00 |
| Sep 30, 2017 | -750.00 |
| Jun 30, 2017 | 1,029.00 |
| Jun 30, 2017 | 1,029.00 |
| Mar 31, 2017 | 750.00 |
| Mar 31, 2017 | 750.00 |
| Dec 31, 2016 | -750.00 |
| Dec 31, 2016 | -750.00 |